Cadrenal Therapeutics
CVKD
#10120
Rank
โ‚ฌ19.71 M
Marketcap
9,50ย โ‚ฌ
Share price
11.43%
Change (1 day)
-20.87%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2025 (TTM): -6,59ย โ‚ฌ

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -6,37ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -7,46ย โ‚ฌ an increase over its 2023 EPS that were of -7,94ย โ‚ฌ.

EPS history for Cadrenal Therapeutics from 2023 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-6,59ย โ‚ฌ-11.65%
2024-7,46ย โ‚ฌ-6.03%
2023-7,94ย โ‚ฌ